Inceptor Bio
Raleigh
About Inceptor Bio
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers, with a focus on novel mechanisms to improve immune cell performance in the tumor microenvironment. Inceptor Bio provides a partnership model to university research programs focused on cutting-edge therapeutic approaches for oncology. The combination of their lab and manufacturing resources with the industry experience of their cell and gene therapy experts will advance therapeutics into the clinic with remarkable efficiency.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $108.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2025)
- Website: inceptor.bio
- Phone: (919) 521-6400
Industries & Categories
Biotechnology, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/inceptor-bio-92248 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.